It’s happening in Mandarin Chinese as well, with the new character X也, which combines the Roman letter X with an element that ...

This study presents a comprehensive approach for assessing multiple quality attributes of antibody-oligonucleotide conjugates ...

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

Biologically, how the GLP-1 is delivered into the body should make little difference: It’s the same peptide, just in a ...

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

The integration of flexible manufacturing, process intensification, and sustainability is redefining the global supply chain.

GovCIO is proud to mark the successful early deployment of Phase 1 of the Readiness and Employment System (RES), a major ...

How HTGF combines government backing and industrial partnerships with a VC mindset to crowd in private capital and support ...

Drs. Gulden Menderes and Levent Mutlu, gynecological oncologists with Health First Medical Group, stress to women to speak up.

Biopharma enters 2026 amid continuing scientific progress and accelerating deal activity, yet its business model is under pressure across every facet of the value chain. Investors are taking note: ...

The move, criticized by some health experts as promoting vaccine distrust, comes amid a surge in flu cases.